News und Analysen
Chemed To Report Second-Quarter 2022 Earnings July 27, Related Conference Call To Be Held On July 28
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2022, on Wednesday, July 27, 2022, following the close of trading on the
Novocure to Report Second Quarter 2022 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2022 on Thursday, July 28, 2022, before the U.S. financial markets open. Novocure’s management
Acadia Healthcare Forms Joint Venture With Tufts Medicine to Build a Behavioral Health Hospital to Serve the Boston Regional Area
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Tufts Medicine, one of Massachusetts’ elite health systems. The partnership anticipates
Tufts Medicine and Melrose Wakefield Hospital Partner With Acadia Healthcare to Build Inpatient Behavioral Health Hospital to Serve Regional Boston Area
Tufts Medicine, a leading Massachusetts consumer oriented health system, and Acadia Healthcare Company, the largest standalone provider of behavioral health services in the U.S., announced today
Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility
Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $550 million of amended and restated senior secured credit facilities (“Credit Facilities”). JPMorgan Chase Bank, N.A
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Charles River Laboratories International, Inc. (NYSE: CRL) and Ziphius Vaccines, a biopharmaceutical company developing self-amplifying RNA (saRNA) based medicinal products for vaccine and
Premier Inc. Honors Indiana Recovery Home for Women with National Award and $100,000 Prize
The BreakAway, a nonprofit dedicated to helping women recover from the disease of addiction in New Albany, IN, has received the 2022 Monroe E. Trout Premier Cares Award and a $100,000 cash prize
Henry Ford Health Wins 2022 Premier Alliance Excellence Award
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has named Henry Ford Health, an integrated nonprofit health system providing a full continuum of services
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its phase 2 pilot KEYNOTE-B36 study, conducted in collaboration with MSD, a tradename of Merck & Co., Inc., Rahway
AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program
The Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (NYSE: AMN, the “Company”) authorized an additional $250 million under the Company’s repurchase program for the company’s
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
Charles River Laboratories International, Inc. (NYSE: CRL) and ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in vivo gene replacement
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Healthcare Conference on Wednesday, June 8th, at 10:00 a.m. ET, and at the William
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, and Zai Lab (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage
Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference
Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately 8:00 a.m. (ET) in New York
AMN Healthcare Survey: Most Healthcare Facilities Using Locum Tenens Physicians to Fill Vacancies
Nearly 90% of healthcare facilities used locum tenens physicians and/or advanced practice professionals to fill gaps in their staffs last year, according to a new survey from AMN Healthcare, the
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported initial
AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses
AMN Healthcare, the nation’s leader in healthcare total talent solutions, has been named Prime Supplier of the Year by the Western Regional Minority Supplier Development Council for prioritizing
Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma
Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, to study the use of Tumor Treating
AMN Highest Ranked Healthcare MSP in 2022 Global Customer Satisfaction Awards
AMN Healthcare (NYSE: AMN), the nation’s leader in healthcare total talent solutions, achieved the highest ranking for a healthcare Managed Services Program in the HRO Today 2022 Baker’s Dozen
AMN Healthcare Acquires Connetics USA, an International Nurse and Allied Recruitment Company
AMN Healthcare (NYSE: AMN), the nation’s leading total healthcare talent solutions company, has acquired Connetics USA, an international nurse and allied recruitment company that specializes in
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2022 annual stockholders’ meeting. Each of the directors continues from the prior term.
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at approximately 8:00 a.m. (ET)
AMN Healthcare Announces First Quarter 2022 Results
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2022 financial
Xencor Reports First Quarter 2022 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial
Acadia Healthcare to Present at May Conferences
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at two healthcare conferences in May.
On Wednesday, May 11, 2022, the Company will present at the BofA